Seguir
Jan M. Werner
Jan M. Werner
University Hospital Cologne
Dirección de correo verificada de uk-koeln.de
Título
Citado por
Citado por
Año
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
N Galldiks, M Kocher, G Ceccon, JM Werner, A Brunn, M Deckert, ...
Neuro-oncology 22 (1), 17-30, 2020
1152020
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
P Lohmann, P Stavrinou, K Lipke, EK Bauer, G Ceccon, JM Werner, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-12, 2018
882018
FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation
P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ...
Cancers 12 (12), 3835, 2020
762020
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI
JM Werner, G Stoffels, T Lichtenstein, J Borggrefe, P Lohmann, G Ceccon, ...
European journal of nuclear medicine and molecular imaging 46, 1889-1901, 2019
612019
Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients
P Lohmann, JM Werner, NJ Shah, GR Fink, KJ Langen, N Galldiks
Cancers 11 (2), 153, 2019
602019
Discordance and conversion rates of progesterone-, estrogen-, and HER2/neu-receptor status in primary breast cancer and brain metastasis mainly triggered by hormone therapy
M Timmer, JM Werner, G Roehn, M Ortmann, T Blau, C Cramer, ...
Anticancer research 37 (9), 4859-4865, 2017
432017
Current landscape and emerging fields of PET imaging in patients with brain tumors
JM Werner, P Lohmann, GR Fink, KJ Langen, N Galldiks
Molecules 25 (6), 1471, 2020
362020
Dabrafenib treatment in a patient with an epithelioid glioblastoma and BRAF V600E mutation
G Ceccon, JM Werner, V Dunkl, C Tscherpel, G Stoffels, A Brunn, ...
International journal of molecular sciences 19 (4), 1090, 2018
362018
Early treatment response assessment using 18F-FET PET compared with contrast-enhanced MRI in glioma patients after adjuvant temozolomide chemotherapy
G Ceccon, P Lohmann, JM Werner, C Tscherpel, V Dunkl, G Stoffels, ...
Journal of nuclear medicine 62 (7), 918-925, 2021
312021
Treatment monitoring of immunotherapy and targeted therapy using 18F-FET PET in patients with melanoma and lung cancer brain metastases: initial experiences
N Galldiks, DSY Abdulla, M Scheffler, F Wolpert, JM Werner, M Hüllner, ...
Journal of nuclear medicine 62 (4), 464-470, 2021
292021
Diagnosis of pseudoprogression following lomustine–temozolomide chemoradiation in newly diagnosed glioblastoma patients using FET-PET
JM Werner, J Weller, G Ceccon, C Schaub, C Tscherpel, P Lohmann, ...
Clinical cancer research 27 (13), 3704-3713, 2021
252021
Feature-based PET/MRI radiomics in patients with brain tumors
P Lohmann, AK Meißner, M Kocher, EK Bauer, JM Werner, GR Fink, ...
Neuro-oncology advances 2 (Supplement_4), iv15-iv21, 2020
232020
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET
EK Bauer, G Stoffels, T Blau, G Reifenberger, J Felsberg, JM Werner, ...
European journal of nuclear medicine and molecular imaging 47, 1486-1495, 2020
232020
Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
JM Werner, V Schweinsberg, M Schroeter, B von Reutern, MP Malter, ...
Frontiers in Oncology 9, 84, 2019
222019
Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups
M Trommer, A Adams, E Celik, J Fan, D Funken, JM Herter, P Linde, ...
Cancers 14 (5), 1240, 2022
182022
Use of advanced neuroimaging and artificial intelligence in meningiomas
N Galldiks, F Angenstein, JM Werner, EK Bauer, R Gutsche, GR Fink, ...
Brain pathology 32 (2), e13015, 2022
152022
Simulation-based training of the rapid evaluation and management of acute stroke (STREAM)—a prospective single-arm multicenter trial
FO Bohmann, N Kurka, FA Wollenweber, L Kellert, A Alegiani, C Schubert, ...
Frontiers in neurology 10, 455518, 2019
152019
Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
N Galldiks, JM Werner, C Tscherpel, GR Fink, KJ Langen
Neuro-oncology advances 1 (1), vdz038, 2019
132019
Flare phenomenon in O-(2-18F-fluoroethyl)-l-tyrosine PET after resection of gliomas
CP Filss, AK Schmitz, G Stoffels, C Stegmayr, P Lohmann, JM Werner, ...
Journal of nuclear medicine 61 (9), 1294-1299, 2020
122020
Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors
N Galldiks, P Lohmann, JM Werner, G Ceccon, GR Fink, KJ Langen
Expert review of anticancer therapy 20 (1), 9-15, 2020
122020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20